Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Cancer Biology · Sri Lanka · 2026-01-26

Processing Time
69 days
Decision Date
2026-01-26
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on elucidating molecular mechanisms and identifying novel therapeutics for rare and advanced metastatic cancers. The work involves using cell-based assays, advanced biotechnological approaches, and computer-aided drug design to advance personalized medicine and improve patient survival outcomes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the urgent need for improved treatment of rare and advanced metastatic cancers and aligns with the Cancer Moonshot initiative.

2 Well-positioned to Advance the Endeavor Met

The petitioner's credentials, including a Ph.D., 100 citations, and major funding, demonstrate they are well-positioned to lead this research.

3 Balance of Interests Met

The innovative nature of the work and its direct application to patient survival make it beneficial for the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in medical sciences and a portfolio of 5 peer-reviewed journal articles and 26 abstracts. The work garnered 100 citations and was supported by competitive funding from the Neuroendocrine Tumor Research Foundation. All three Dhanasar prongs were satisfied within a 2-month processing period without an RFE.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Sri Lanka

Case data sourced from publicly available petition decisions and case studies. Decision date: 2026-01-26.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 69 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Sri Lanka All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist